| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 32,440 | 32,785 | 17:42 | |
| 32,440 | 32,785 | 17:42 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 32,695 | 939 | |||
| 32,690 | 603 | |||
| 32,685 | 619 | |||
| 32,680 | 1.953 | |||
| 32,675 | 941 | |||
| 32,670 | 954 | |||
| 32,665 | 1.025 | |||
| 32,660 | 550 | |||
| 32,655 | 630 | |||
| 32,650 | 402 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/qia.htm [/URL] | ||||
| 58 | 32,630 | |||
| 1.089 | 32,625 | |||
| 794 | 32,620 | |||
| 1.314 | 32,615 | |||
| 1.133 | 32,610 | |||
| 1.145 | 32,605 | |||
| 1.862 | 32,600 | |||
| 605 | 32,595 | |||
| 424 | 32,590 | |||
| 413 | 32,585 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 8.837 | 0,975 | 8.616 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:26:52 | 32,660 | 109 |
| 17:26:47 | 32,660 | 130 |
| 17:26:47 | 32,650 | 368 |
| 17:26:42 | 32,670 | 220 |
| 17:26:38 | 32,650 | 121 |
| 17:26:37 | 32,670 | 253 |
| 17:26:32 | 32,670 | 290 |
| 17:26:27 | 32,665 | 380 |
| 17:26:11 | 32,665 | 111 |
| 17:26:11 | 32,660 | 15 |
| 17:25:48 | 32,640 | 157 |
| 17:25:29 | 32,630 | 204 |
| 17:24:57 | 32,635 | 86 |
| 17:24:57 | 32,630 | 505 |
| 17:24:31 | 32,620 | 178 |
| 17:24:25 | 32,630 | 399 |
| 17:24:25 | 32,630 | 869 |
| 17:24:25 | 32,630 | 265 |
| 17:23:57 | 32,620 | 84 |
| 17:23:57 | 32,620 | 68 |
| Tagesumsatz Xetra | +0,100 +0,31 % | 184.031 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Aktien New York Ausblick: Moderate Gewinne - Lage in Nahost sorgt für Vorsicht | 687 | dpa-AFX | NEW YORK (dpa-AFX) - Am US-Aktienmarkt werden am Dienstag zum Handelsstart moderate Gewinne erwartet. Angesichts der unsicheren Lage in Nahost dominiert - wie bereits zum Wochenstart - die Vorsicht.... ► Artikel lesen | |
| 16.04. | QIAGEN N.V.: QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026 | 611 | Business Wire | Highlights solutions addressing key oncology research needs across automated sample preparation, single-cell analysis, genomic profiling and data analysis QIAsymphony Connect will serve... ► Artikel lesen | |
| 14.04. | Qiagen erweitert Portfolio um Test für Blutstrominfektionen | 36 | Investing.com Deutsch | ||
| 14.04. | Qiagen launches bloodstream infection testing panel | 8 | Investing.com | ||
| QIAGEN Aktie jetzt für 0€ handeln | |||||
| 14.04. | QIAGEN N.V.: QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel | 503 | Business Wire | QIAstat-Dx BCID GPF Plus AMR Panel detects gram-positive bacteria, fungi and key antimicrobial resistance markers from positive blood cultures and colonies CE-IVDR-certified panel identifies... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 14:00 | RedHill Biopharma Ltd.: RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights | PR Newswire | 2025 was a year of tenacity, strategic transactions and building traction for RedHill
Talicia® business transformed:
Formation of Talicia Holdings Inc. (THI) and... ► Artikel lesen | |
| 14:30 | Morning Market Movers: Sagimet Biosciences, Compass Therapeutics, Oruka Therapeutics, Veradermics See Big Swings | AFX News | SAN DIEGO (dpa-AFX) - At 8:00 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 15:09 | EQS-News: GeoVax, Inc.: GeoVax Highlights Gedeptin(R) as a Potential Immune-Sensitizing Platform Amid Rising Industry Investment in In Vivo Cancer Therapies | EQS Group (EN) | EQS-News: GeoVax, Inc.
/ Key word(s): Financial
GeoVax Highlights Gedeptin(R) as a Potential Immune-Sensitizing Platform Amid Rising Industry Investment in In Vivo Cancer Therapies... ► Artikel lesen | |
| 14:10 | Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer | GlobeNewswire (Europe) | Management remit expansion reflecting organization alignment to maximize external engagement and strategy execution
COPENHAGEN, Denmark, April 27, 2026 - Evaxion A/S (NASDAQ: EVAX) ("Evaxion"),... ► Artikel lesen | |
| 14:02 | Hypha Labs, Inc.: Trump Psychedelic Executive Order Accelerates Industry Growth | ACCESS Newswire | Hypha Labs, Inc. (FUNI) Positioned to Lead with AI-Driven Production Technology LAS VEGAS, NV / ACCESS Newswire / April 27, 2026 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology innovator focused on... ► Artikel lesen |